Bio Net Income from 2010 to 2026

BIO Stock  USD 293.70  1.21  0.41%   
Bio Rad Net Loss yearly trend continues to be very stable with very little volatility. Net Loss is likely to grow to about -2 B this year. During the period from 2010 to 2026, Bio Rad Net Loss quarterly data regression pattern had range of 7.9 B and standard deviation of  1,959,985,048. View All Fundamentals
 
Net Loss  
First Reported
1985-09-30
Previous Quarter
317.8 M
Current Value
-341.9 M
Quarterly Volatility
539.2 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 183.1 M, Interest Expense of 59 M or Selling General Administrative of 492 M, as well as many indicators such as Price To Sales Ratio of 3.41, Dividend Yield of 0.0 or PTB Ratio of 2.12. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Build AI portfolio with Bio Stock
Check out the analysis of Bio Rad Correlation against competitors.
Evaluating Bio Rad's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Bio Rad Laboratories's fundamental strength.

Latest Bio Rad's Net Income Growth Pattern

Below is the plot of the Net Income of Bio Rad Laboratories over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Bio Rad Laboratories financial statement analysis. It represents the amount of money remaining after all of Bio Rad Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Bio Rad's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Rad's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (1.84 B)10 Years Trend
Pretty Stable
   Net Income   
       Timeline  

Bio Net Income Regression Statistics

Arithmetic Mean42,225,265
Coefficient Of Variation4,642
Mean Deviation1,236,215,218
Median88,845,000
Standard Deviation1,959,985,048
Sample Variance3841541.4T
Range7.9B
R-Value(0.26)
Mean Square Error3821251.4T
R-Squared0.07
Significance0.31
Slope(100,804,260)
Total Sum of Squares61464662.2T

Bio Net Income History

2026-2 B
2025-2.1 B
2024-1.8 B
2023-637.3 M
2022-3.6 B
20214.3 B
20203.8 B

Other Fundumenentals of Bio Rad Laboratories

Bio Rad Net Income component correlations

About Bio Rad Financial Statements

Bio Rad investors utilize fundamental indicators, such as Net Income, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-2.1 B-2 B
Net Loss-2.1 B-2 B
Net Loss-1.7 B-1.6 B
Net Loss(58.83)(55.89)
Net Income Per E B T 0.71  0.58 

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

  0.43BRK-B Berkshire HathawayPairCorr
  0.37SPGX Sustainable ProjectsPairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Will Life Sciences Tools & Services sector continue expanding? Could Bio diversify its offerings? Factors like these will boost the valuation of Bio Rad. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bio Rad data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.83)
Earnings Share
(23.91)
Revenue Per Share
92.937
Quarterly Revenue Growth
0.005
Return On Assets
0.0157
Bio Rad Laboratories's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Rad's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bio Rad's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Rad's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Rad should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.